Back to search

Belgium· BE-AMP-SAM277444-00

Lipoplus 200 mg/ml

A fettemulsionen product containing omega-3-acid triglycerides, registered in Belgium by B. Braun Melsungen. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLipoplus 200 mg/mlATCB05BA02REGISTER NO.BE-AMP-SAM277444-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Omega-3-Acid Triglycerides
Manufacturer
B. Braun Melsungen
Country
Belgium (BE)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fettemulsionen in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fettemulsionen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Italy · Omega 3 Teva Italia
  • Romania · Tevocor
  • Slovakia · Essentiale

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7598b49e-a50f-465a-ae76-92065e4e07bb
GET /v1/drugs/7598b49e-a50f-465a-ae76-92065e4e07bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsion for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Lipoplus 200 mg/ml",
  "name_fr": "Lipoplus 200 mg/ml",
  "name_nl": "Lipoplus 200 mg/ml",
  "amp_code": "SAM277444-00",
  "strengths": [
    "20.0000",
    "100.0000",
    "80.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Omega-3-Acid Triglycerides",
    "Triglycerides Medium Chain",
    "Soya Oil"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fat Emulsions",
  "authorisation_numbers": [
    "BE277453",
    "BE277462"
  ]
}

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.